• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    New CIO Appointment and AI Focus Might Change The Case For Investing In Centene (CNC)

    Simply Wall St·09/04/2026 17:22:12
    Listen to the news
    • Centene Corporation recently appointed Bradley Bolivar as Chief Information Officer, succeeding retiring CIO Brian LeClaire, bringing nearly three decades of technology leadership across financial services, media and consulting, including leading enterprise-wide AI, data and cybersecurity initiatives at Fannie Mae.
    • The move underscores Centene’s push to use data, artificial intelligence and automation to refine operations and resilience at a time of improving profitability but pressure on enrollment in key segments.
    • We’ll now examine how Bolivar’s technology and AI focus could influence Centene’s investment narrative around Medicaid margin recovery and earnings quality.

    Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

    Centene Investment Narrative Recap

    To own Centene, you need to believe its Medicaid and government program margins can recover while it manages policy risk and volatile medical costs. The CIO appointment supports the near term catalyst around margin quality by aiming to sharpen data, AI and automation, but does not materially change the biggest risk, which remains reimbursement and policy uncertainty across Medicaid and Marketplace.

    Against that backdrop, Centene’s recent 2026 guidance increase, with revenue now expected between US$193.5 billion and US$197.5 billion and a higher EPS floor, is the announcement that most directly frames this CIO change. Stronger current profitability makes the push into AI, data and automation feel less like a rescue effort and more like an attempt to reinforce earnings quality as enrollment pressures and cost volatility persist.

    But while earnings are moving the right way, investors should still pay close attention to the possibility that shifting Medicaid policy...

    Read the full narrative on Centene (it's free!)

    Centene's narrative projects $205.6 billion revenue and $3.2 billion earnings by 2029. This requires 4.5% yearly revenue growth and a $8.3 billion earnings increase from -$5.1 billion today.

    Uncover how Centene's forecasts yield a $71.67 fair value, a 5% upside to its current price.

    Exploring Other Perspectives

    CNC 1-Year Stock Price Chart
    CNC 1-Year Stock Price Chart

    Some of the most optimistic analysts were already assuming revenue around US$209.5 billion and earnings near US$3.7 billion by 2029, and saw AI driven cost control as a powerful accelerator; you may read that as a far more optimistic story than consensus, and this CIO shift could either reinforce or challenge that view depending on how you weigh the execution and policy risks.

    Explore 7 other fair value estimates on Centene - why the stock might be worth over 2x more than the current price!

    Reach Your Own Conclusion

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

    Looking For Alternative Opportunities?

    Every day counts. These free picks are already gaining attention. See them before the crowd does:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.